Welcome to our dedicated page for Cardlytics news (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics stock.
Cardlytics, Inc. (NASDAQ: CDLX) is a commerce media platform in the advertising services space that regularly issues news and updates through press releases and SEC-related announcements. The company’s news flow reflects its focus on using publishers’ first-party purchase data, card-linked offers, and identity resolution capabilities to help advertisers and publishers strengthen customer loyalty.
On this page, readers can find Cardlytics news related to quarterly financial results, cost-optimization initiatives, leadership changes, partnerships, and platform developments. Recent updates have included earnings releases for multiple quarters, detailing metrics such as Billings, Adjusted Contribution, Adjusted EBITDA, and key operating indicators like monthly qualified users (MQUs) and adjusted contribution per user (ACPU). These releases often provide context on how management views the company’s performance and operating environment.
Cardlytics also announces corporate and strategic actions such as workforce reduction plans intended to optimize its cost structure, repayment of convertible senior notes, and amendments to key agreements with partners. In addition, the company issues news on executive appointments and equity compensation arrangements, including the appointment of its Chief Financial Officer and inducement equity grants under its plans.
Sector-specific news features partnerships and network expansion through Bridg and the Rippl Retail Media Network, including collaborations with regional grocers and retail media networks. Cardlytics has also highlighted recognition of its card-linked offer network in industry awards programs, underscoring the role of its CLO network within the digital advertising ecosystem.
Investors, analysts, and other interested readers can use this news feed to follow Cardlytics’ reported financial performance, strategic decisions, and developments across its Cardlytics and Bridg platforms. Regularly reviewing these updates can provide insight into how the company manages its commerce media operations, relationships with publishers and advertisers, and its approach to cost structure and capital management.
PAR Technology (NYSE: PAR) agreed to acquire substantially all assets of Bridg from Cardlytics for a base purchase price of $27.5 million, subject to adjustments with a maximum total of $30.0 million, payable in PAR common stock. The deal is expected to close in Q1 2026 and PAR will assume certain liabilities.
The acquisition adds Bridg’s identity resolution and shopper intelligence platform to PAR’s offering, combining loyalty and non‑loyalty transactions to enable end‑to‑end customer visibility, addressable audiences, and closed‑loop attribution for retailers, restaurants, and CPG companies.
Cardlytics (NASDAQ: CDLX) announced that on January 12, 2026 its Compensation Committee granted an aggregate of 1,000,000 restricted stock units (RSUs) to newly appointed Chief Financial Officer David Evans as a material inducement under Nasdaq Listing Rule 5635(c)(4).
Half of the RSUs vest on February 1, 2027 and the remaining 50% vest quarterly over the following 12 months, subject to Evans' continuous service, all under the 2022 Inducement Plan.
Cardlytics (NASDAQ: CDLX) named David Evans as Chief Financial Officer, effective January 12, 2026. Evans returns after serving at Cardlytics from 2014–2020, including leadership through the company’s 2018 IPO. He will oversee finance, accounting, and investor relations as the company executes its longer-term growth vision. Evans joins from advisory and board roles, currently serving as Board Chair at Neighborly Software. Alexis DeSieno is stepping down as CFO and will remain in a non-officer advisory role through March 6, 2026 to support the transition.
Cardlytics (NASDAQ: CDLX) reported Q3 2025 results for the quarter ended September 30, 2025. Revenue was $52.0M (down 22% YoY) and Billings were $89.2M (down 20% YoY). Adjusted Contribution was $30.0M (down 17% YoY) and Adjusted EBITDA was $3.2M versus a loss in Q3 2024. Net loss narrowed to $(72.7)M from $(145.2)M. Monthly qualified users reached 230.3M (+21% YoY) while adjusted contribution per user was $0.11 versus $0.16 a year ago. Q4 2025 guidance: Billings $86.0–$96.0M; Revenue $51.1–$59.1M; Adjusted Contribution $29.0–$35.0M; Adjusted EBITDA $0.9–$7.9M.
Cardlytics (NASDAQ: CDLX) will release third quarter 2025 financial results for the period ending September 30, 2025 on November 5, 2025 after market close.
The company will host a conference call the same day at 5:00 PM ET / 2:00 PM PT with a live audio webcast accessible on the Cardlytics investor relations website and a replay available after the call. Dial-in: +1 800-549-8228; Conference ID: 18219.
Cardlytics (NASDAQ: CDLX) has announced a significant workforce reduction and cost-saving initiative, cutting approximately 120 full-time employees and contractors, representing 30% of its total workforce. The company expects to incur $2.3 million in severance expenses, primarily in Q4 2025.
The enterprise-wide cost savings program, which includes reductions in third-party spending, real estate, and operations, is projected to deliver annualized cash savings of at least $26 million. Despite these changes, Cardlytics remains committed to achieving positive adjusted EBITDA for both 2025 and 2026.
Cardlytics (NASDAQ: CDLX) has announced the complete repayment of its $46.1 million 1.00% convertible senior notes due September 15, 2025. Following this debt settlement, the company's remaining debt obligations include $172.5 million in 4.25% convertible senior notes due 2029 and $50 million drawn on its line of credit.
The company reported $92.7 million in cash and cash equivalents as of August 31, 2025, and maintains compliance with all financial covenants. Management emphasized their focus on disciplined cash management and commitment to achieving positive adjusted EBITDA for 2025 and 2026.
Cardlytics (NASDAQ: CDLX) has been awarded the "Best Digital Ad Network" in the 2025 MarTech Breakthrough Awards program. The company's card-linked offer (CLO) network was selected from over 4,000 global submissions, recognized for its innovative approach and targeting capabilities.
Cardlytics operates the leading financial media network in the U.S. and U.K., reaching nearly 225 million consumers with visibility into $5.8 trillion in annual consumer spend. The platform delivers targeted cash back offers to help build customer loyalty, connecting advertisers with value-conscious shoppers through their network of publisher partners.
Cardlytics (NASDAQ: CDLX) reported mixed Q2 2025 financial results, showing revenue decline but improved profitability metrics. Revenue decreased 9% year-over-year to $63.2 million, while billings fell 6% to $104.0 million. The company reported a net loss of $(9.3) million, or $(0.18) per share, compared to $(4.3) million loss in Q2 2024.
Despite challenges, Cardlytics showed operational improvements with Adjusted EBITDA of $2.7 million, compared to $(2.3) million loss last year. Monthly qualified users increased significantly by 19% to 224.5 million. For Q3 2025, the company expects billings between $87.0-$95.0 million, representing a year-over-year decline of 15-22%.
CEO Amit Gupta emphasized the company's focus on diversification efforts and network capabilities to navigate current headwinds and position for long-term profitable growth.
Cardlytics (NASDAQ: CDLX) has granted 454,600 restricted stock units (RSUs) to two newly hired employees as inducement awards. The grants were approved by the Compensation Committee of Cardlytics' Board of Directors on July 30, 2025.
The RSUs were awarded under the company's 2022 Inducement Plan, with a vesting schedule of 50% after one year and the remaining 50% vesting quarterly over the following 12 months, contingent on continued employment. These grants comply with Nasdaq Listing Rule 5635(c)(4) regarding material inducement grants.
FAQ
What is the current stock price of Cardlytics (CDLX)?
What is the market cap of Cardlytics (CDLX)?
